RxDoctor Payments Data

Jeffrey Kulp, MD

Geriatric Medicine · Colorado Springs, CONPI 1972506053

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Inspire Medical Systems, Inc. accounts for 62.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $120 and has fallen 84.2% since, to $19 in 2025.

$192in general payments, 2019–2025

Across 6 payments — averaging $31.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$120
  • Astellas Pharma US Inc$22
  • Biomerieux Inc$19
  • GSK$16
  • Medtronic$14

What the payments were for

  • Food & beverage$192100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$192 in reported general payments places this provider in the 65th percentile of 74 geriatric medicine providers in Colorado.

See all geriatric medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$211,842
Medicare patients
396
Services billed
3,016

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban108$130,154
TrulicityDulaglutide28$40,225
ArexvyRsvpref3 Antigen/As01e/Pf126$38,834
OzempicSemaglutide25$37,461
XareltoRivaroxaban33$29,338
ShingrixVaricella-Zoster Ge/As01b/Pf112$24,816
JardianceEmpagliflozin17$14,709
Repatha SureclickEvolocumab15$11,647
MyrbetriqMirabegron14$10,591
SymbicortBudesonide/Formoterol Fumarate25$8,672
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,967
PremarinEstrogens, Conjugated12$6,350
Gabapentin190$5,505
BrilintaTicagrelor11$5,205
Levothyroxine Sodium360$3,991

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKArexvy, Shingrix, Trelegy Ellipta$16$70,617249 claims
Astellas Pharma US IncMyrbetriq$22$10,59114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 74 geriatric medicine providers in Colorado.

Other geriatric medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →